Tetraline derivatives as ghrelin receptor modulators

   
   

The present invention is related to compounds of formula (I), 1 or a therapeutically suitable salt or prodrug thereof, the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by ghrelin including anorexia, cancer cachexia, eating disorders, age-related decline in body composition, weight gain, obesity, and diabetes mellitus.

A invenção atual é relacionada aos compostos da fórmula (i), o 1 ou um sal ou um prodrug therapeutically apropriado disso, a preparação dos compostos, as composições que contêm os compostos e o uso dos compostos na prevenção ou o tratamento dos disorders regulados pelo ghrelin including o anorexia, caquexia do cancer, comendo disorders, declínio age-related na composição do corpo, ganho do peso, obesity, e mellitus do diabetes.

 
Web www.patentalert.com

< Tetrahydroquinoline derivatives as cannabinoid receptor modulators

< Amide derivatives as selective serotonin re-uptake inhibitors

> Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity

> Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cycloh- epta[1,2-b]furan derivatives

~ 00157